ReviewPharmaceuticals (Basel, Switzerland)2021

Peptide Inhibitors of Kv1.5: An Option for the Treatment of Atrial Fibrillation.

Jesús Borrego et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.